Seguir
Alyssa Kosmides Galaro
Alyssa Kosmides Galaro
Food and Drug Administration
Dirección de correo verificada de jhmi.edu
Título
Citado por
Citado por
Año
Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation
RA Meyer, JC Sunshine, K Perica, AK Kosmides, K Aje, JP Schneck, ...
Small (Weinheim an der Bergstrasse, Germany) 11 (13), 1519, 2015
1822015
Metabolomic fingerprinting: challenges and opportunities
AK Kosmides, K Kamisoglu, SE Calvano, SA Corbett, I Androulakis
Critical Reviews™ in Biomedical Engineering 41 (3), 2013
1792013
Dual targeting nanoparticle stimulates the immune system to inhibit tumor growth
AK Kosmides, JW Sidhom, A Fraser, CA Bessell, JP Schneck
ACS nano 11 (6), 5417-5429, 2017
1502017
Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma
AK Kosmides, RA Meyer, JW Hickey, K Aje, KN Cheung, JJ Green, ...
Biomaterials 118, 16-26, 2017
1052017
Separating T cell targeting components onto magnetically clustered nanoparticles boosts activation
AK Kosmides, K Necochea, JW Hickey, JP Schneck
Nano letters 18 (3), 1916-1924, 2018
612018
Linking form to function: Biophysical aspects of artificial antigen presenting cell design
K Perica, AK Kosmides, JP Schneck
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (4), 781-790, 2015
522015
ImmunoMap: a bioinformatics tool for T-cell repertoire analysis
JW Sidhom, CA Bessell, JJ Havel, A Kosmides, TA Chan, JP Schneck
Cancer immunology research 6 (2), 151-162, 2018
412018
Engineering platforms for t cell modulation
JW Hickey, AK Kosmides, JP Schneck
International Review of Cell and Molecular Biology 341, 277-362, 2018
152018
Pulsatile glucocorticoid secretion: origins and downstream effects
JD Scheff, AK Kosmides, SE Calvano, SF Lowry, IP Androulakis
IEEE transactions on biomedical engineering 58 (12), 3504-3507, 2011
152011
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016
A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ...
Journal for immunotherapy of cancer 4, 1-106, 2016
102016
ImmunoMap: a bioinformatics tool for T-cell repertoire analysis. Cancer Immunol. Res. 2018; 6: 151–162. doi: 10.1158/2326-6066
JW Sidhom, CA Bessell, JJ Havel, A Kosmides, TA Chan, JP Schneck
CIR-17-0114.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
8
Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment
AK Kosmides, J Schneck
Journal for ImmunoTherapy of Cancer 2 (Suppl 3), P108, 2014
22014
Immunoswitch nanoparticles for reprogrammed t cell responses
AK Kosmides, JP Schenck
US Patent App. 16/327,508, 2019
12019
Biomimicry of the Antigen Presenting Cell: The Importance of Size and Shape
R Meyer, A Kosmides, JP Schneck, JJ Green
TISSUE ENGINEERING PART A 22, S39-S39, 2016
12016
Production of antigen-specific t-cells
M Oelke, JL Santos, S Kim, J Schneck, A Kosmides
US Patent App. 18/111,975, 2023
2023
Production of antigen-specific t-cells
M Oelke, JL Santos, S Kim, J Schneck, A Kosmides
US Patent App. 16/084,121, 2020
2020
PRODUCTION OF T CELLS SPECIFIC TO ANTIGENS
M Oelke, JL SANTOS, S Kim, J Schneck, A KOSMIDES
2019
Utilizing nanotechnology to improve the activation of CD8 T cells for cancer immunotherapy
AK Kosmides
Johns Hopkins University, 2018
2018
Immunoswitch particles target activation of anti-tumor CD8+ T cells to inhibit tumor growth
A Kosmides, JW Sidhom, A Fraser, C Bessell, J Schneck
JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017
2017
Production of antigen-specific t-cells
M Oelke, JL Santos, S Kim, J Schneck, A KOSMIDES
2017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20